Restless legs syndrome due to interferon-α

Jeffrey S. LaRochelle; Barbara I. Karp

doi:10.1002/mds.20049

Restless legs syndrome due to interferon-α

Jeffrey S. LaRochelle, Barbara I. Karp^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Abstract

A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment.

Original language	English
Pages (from-to)	730-731
Number of pages	2
Journal	Movement Disorders
Volume	19
Issue number	6
DOIs	https://doi.org/10.1002/mds.20049
State	Published - Jun 2004
Externally published	Yes

Keywords

Interferon-α
Movement Disorder
Restless legs syndrome

Access to Document

10.1002/mds.20049

Cite this

@article{ecfc6b956092425cb567b84bb1fa0732,

title = "Restless legs syndrome due to interferon-α",

abstract = "A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment.",

keywords = "Interferon-α, Movement Disorder, Restless legs syndrome",

author = "LaRochelle, {Jeffrey S.} and Karp, {Barbara I.}",

year = "2004",

month = jun,

doi = "10.1002/mds.20049",

language = "English",

volume = "19",

pages = "730--731",

journal = "Movement Disorders",

issn = "0885-3185",

number = "6",

}

TY - JOUR

T1 - Restless legs syndrome due to interferon-α

AU - LaRochelle, Jeffrey S.

AU - Karp, Barbara I.

PY - 2004/6

Y1 - 2004/6

N2 - A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment.

AB - A patient developed restless legs symptoms paralleling the course of interferon-α (IFNα) therapy for chronic hepatitis C. Symptoms began during a course of IFNα, resolved with its suspension, and recurred on rechallenge. Restless legs syndrome may thus be an adverse effect of IFNα treatment.

KW - Interferon-α

KW - Movement Disorder

KW - Restless legs syndrome

UR - http://www.scopus.com/inward/record.url?scp=4444265717&partnerID=8YFLogxK

U2 - 10.1002/mds.20049

DO - 10.1002/mds.20049

M3 - Article

C2 - 15197722

AN - SCOPUS:4444265717

SN - 0885-3185

VL - 19

SP - 730

EP - 731

JO - Movement Disorders

JF - Movement Disorders

IS - 6

ER -

Restless legs syndrome due to interferon-α

Abstract

Keywords

Access to Document

Fingerprint

Cite this